Sarcoid-like Reaction Induced by Neoadjuvant Immunotherapy in Stage III Non-small Cell Lung Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Paydas S
. Sarcoid-like reaction in cases treated by checkpoint inhibitors. Med Oncol. 2021; 38(3):29.
DOI: 10.1007/s12032-021-01477-y.
View
2.
Chorti E, Kanaki T, Zimmer L, Hadaschik E, Ugurel S, Gratsias E
. Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis. Eur J Cancer. 2020; 131:18-26.
DOI: 10.1016/j.ejca.2020.02.024.
View
3.
Guo L, Zhang H, Chen B
. Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor. J Cancer. 2017; 8(3):410-416.
PMC: 5332892.
DOI: 10.7150/jca.17144.
View
4.
Danlos F, Pages C, Baroudjian B, Vercellino L, Battistella M, Mimoun M
. Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma. Chest. 2016; 149(5):e133-6.
DOI: 10.1016/j.chest.2015.10.082.
View
5.
Montaudie H, Pradelli J, Passeron T, Lacour J, Leroy S
. Pulmonary sarcoid-like granulomatosis induced by nivolumab. Br J Dermatol. 2016; 176(4):1060-1063.
DOI: 10.1111/bjd.14808.
View